Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada

Abstract Background Treatment guidelines suggest either a low-dose or high-dose approach when prescribing amikacin for nontuberculous mycobacterial pulmonary disease (NTM PD), but data supporting the low-dose approach are limited. The purpose of this study was to describe the safety and efficacy of...

Full description

Bibliographic Details
Published in:	BMC Pharmacology and Toxicology
Main Authors:	Maria Luisa Aznar, Theodore K. Marras, Ahmed Said Elshal, Mahtab Mehrabi, Sarah K. Brode
Format:	Article
Language:	English
Published:	BMC 2019-06-01
Subjects:	Amikacin NTM lung disease Nontuberculous mycobacteria
Online Access:	http://link.springer.com/article/10.1186/s40360-019-0302-1

Similar Items

Nontuberculous mycobacterial axillary lymphadenitis in children
by: Jerome A. Lindeboom, et al.
Published: (2021-05-01)

Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012
by: Lauren C. Ramsay, et al.
Published: (2020-09-01)

Editorial: Nontuberculous mycobacterial pulmonary disease: immunopathogenesis and immunological risk factors
by: Edward D. Chan, et al.
Published: (2025-03-01)

Nontuberculous Mycobacteria in Portugal: Trends from the last decade
by: A. Santos, et al.
Published: (2024-07-01)

Epidemiology of nontuberculous mycobacteria in the Finger Lakes region of New York
by: Michael Croix, et al.
Published: (2024-12-01)

Early-Phase Adverse Effects and Management of Liposomal Amikacin Inhalation for Refractory Mycobacterium avium Complex Lung Disease in Real-World Settings
by: Morita A, et al.
Published: (2022-07-01)

Increasing and More Commonly Refractory Mycobacterium avium Pulmonary Disease, Toronto, Ontario, Canada
by: Daan Raats, et al.
Published: (2022-08-01)

Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada
by: Sarah K. Brode, et al.
Published: (2017-11-01)

Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease
by: Xuanyou Jin, et al.
Published: (2020-11-01)

Comment on “nontuberculous mycobacterial infection after lung transplantation: a report of four cases”
by: Masoud Keikha, et al.
Published: (2019-07-01)

First Case Reports of Nontuberculous Mycobacterial (NTM) Lung Disease in Ecuador: Important Lessons to Learn
by: Gustavo Echeverria, et al.
Published: (2023-03-01)

Pulmonary Nontuberculous Mycobacteria, Ontario, Canada, 2020
by: Theodore K. Marras, et al.
Published: (2023-07-01)

Epidemiology, clinical presentation, and predictors of outcome in nontuberculous mycobacterial central nervous system infection: a systematic review
by: Durga Shankar Meena, et al.
Published: (2023-09-01)

Review and meta analysis of nontuberculous mycobacteria in the Middle East
by: Sanaz Rahideh, et al.
Published: (2015-01-01)

Species Distribution and Isolation Frequency of Nontuberculous Mycobacteria, Uruguay
by: Gonzalo Greif, et al.
Published: (2020-05-01)

Pulmonary Infection and Colonization with Nontuberculous Mycobacteria, Taiwan, 2000–2012
by: Jung-Yien Chien, et al.
Published: (2014-08-01)

Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs
by: Yuzhen Gu, et al.
Published: (2023-10-01)

Pulmonary Nontuberculous Mycobacterial Infection in Infants: A Systematic Review
by: Bai A, et al.
Published: (2021-12-01)

Supporting Patients with Nontuberculous Mycobacterial Pulmonary Disease: Ensuring Best Practice in UK Healthcare Settings
by: Toby Capstick, et al.
Published: (2024-08-01)

Invasive Nontuberculous Mycobacterial Infections among Cardiothoracic Surgical Patients Exposed to Heater–Cooler Devices
by: Meghan M. Lyman, et al.
Published: (2017-05-01)

Demographic and clinical features of nontuberculous mycobacteria infection resulting from cosmetic procedures: a systematic review
by: Xiao Ma, et al.
Published: (2024-12-01)

Epidemiological and clinical characteristics of nontuberculous mycobacterial infections: A retrospective female cohort study in an Italian population
by: Andrea Marino, et al.
Published: (2024-01-01)

Trends from the Last Decade with Nontuberculous Mycobacteria Lung Disease (NTM-LD): Clinicians’ Perspectives in Regional Center of Pulmonology in Bydgoszcz, Poland
by: Grzegorz Przybylski, et al.
Published: (2023-07-01)

Challenges in achieving the guideline-recommended amikacin level for Mycobacterium avium complex pulmonary disease
by: Takuya Akutsu, et al.
Published: (2025-05-01)

Spatial Epidemiologic Analysis and Risk Factors for Nontuberculous Mycobacteria Infections, Missouri, USA, 2008–2019
by: Carlos Mejia-Chew, et al.
Published: (2023-08-01)

Dual Mycobacterial Invasion: A Case Report on Coexisting Tuberculosis and Nontuberculous Mycobacterium Infection
by: P. Prem Ananth, et al.
Published: (2025-01-01)

Nontuberculous mycobacterial infection after lung transplantation: a report of four cases
by: Naoko Ose, et al.
Published: (2019-01-01)

Nontuberculous mycobacterial pulmonary disease (NTM PD) incidence trends in the United States, 2010–2019
by: Samantha J. Bents, et al.
Published: (2024-10-01)

Nontuberculous Mycobacteria Infections at a Provincial Reference Hospital, Cambodia
by: Maryline Bonnet, et al.
Published: (2017-07-01)

Whole-Genome Sequencing Analysis to Identify Infection with Multiple Species of Nontuberculous Mycobacteria
by: Visal Khieu, et al.
Published: (2021-07-01)

Nontuberculous mycobacterial empyema in an immunocompetent child
by: Ira Shah, et al.
Published: (2018-01-01)

The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults
by: Khan O, et al.
Published: (2020-06-01)

Identification and characterization of nontuberculous mycobacteria isolated from suspected pulmonary tuberculosis patients in eastern china from 2009 to 2019 using an identification array system
by: Yelei Zhu, et al.
Published: (2022-03-01)

Delayed CD4 cell recovery in HIV-associated disseminated nontuberculous mycobacterial disease: A case-control study
by: Kai Katzschner, et al.
Published: (2025-11-01)

Nonpharmacological Treatment for Nontuberculous Mycobacterial Pulmonary Disease
by: Hyung-Jun Kim
Published: (2024-10-01)

Epidemiology of and risk factors for extrapulmonary nontuberculous mycobacterial infections in Northeast Thailand
by: Irin Kham-ngam, et al.
Published: (2018-08-01)

Assessment of Drug Resistance in Nontuberculous Mycobacteria
by: Anastasia Kazulina, et al.
Published: (2024-12-01)

Prevalence of Nontuberculous Mycobacteria in Patients Suspected of Tuberculosis and Drug Resistant Tuberculosis
by: Megha Sharma, Gaurav Sharma , Ravi Prakash Shaliwal ,Shipra Bhargava , Bharti Malhotra
Published: (2023-08-01)

Isolation and Antimicrobial Susceptibility of Nontuberculous Mycobacteria in a Tertiary Hospital in Korea, 2016 to 2020
by: Keun Ju Kim, et al.
Published: (2023-01-01)

Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
by: Jimin Zhang, et al.
Published: (2018-05-01)